GPT Healthcare (NSE:GPTHEALTH) ROE %: 21.63% (As of Mar. 2026) — Near Median


NSE:GPTHEALTH GPT Healthcare Ltd NSE:GPTHEALTH
43 GF Score
Price ₹147.51
! 3 Warning Signs
View Full Analysis

What is GPT Healthcare ROE %?

GPT Healthcare NSE:GPTHEALTH -1.61% 43 ROE % is 21.63% as of Mar. 2026, which is 5% below its 10-year median of 22.76. GuruFocus rates NSE:GPTHEALTH with a GF Score™ of 43/100. The stock has 3 warning signs investors should review. Among 625 Healthcare Providers & Services companies, GPT Healthcare ranks better than 78.56% on this metric.

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. GPT Healthcare's annualized net income for the quarter that ended in Mar. 2026 was ₹583 Mil. GPT Healthcare's average Total Stockholders Equity over the quarter that ended in Mar. 2026 was ₹2,694 Mil. Therefore, GPT Healthcare's annualized ROE % for the quarter that ended in Mar. 2026 was 21.63%.

The historical rank and industry rank for GPT Healthcare's ROE % or its related term are showing as below:

NSE:GPTHEALTH' s ROE % Range Over the Past 10 Years
Min: 15.75   Med: 22.76   Max: 28.53
Current: 16.43

During the past 6 years, GPT Healthcare's highest ROE % was 28.53%. The lowest was 15.75%. And the median was 22.76%.

NSE:GPTHEALTH's ROE % is ranked better than
78.56% of 625 companies
in the Healthcare Providers & Services industry
Industry Median: 5.84 vs NSE:GPTHEALTH: 16.43

GPT Healthcare  (NSE:GPTHEALTH) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Mar. 2026 )
=Net Income/Total Stockholders Equity
=582.64/2694.28
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(582.64 / 5054.872)*(5054.872 / 4647.482)*(4647.482 / 2694.28)
=Net Margin %*Asset Turnover*Equity Multiplier
=11.53 %*1.0877*1.7249
=ROA %*Equity Multiplier
=12.54 %*1.7249
=21.63 %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Mar. 2026 )
=Net Income/Total Stockholders Equity
=582.64/2694.28
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (582.64 / 634.592) * (634.592 / 656.728) * (656.728 / 5054.872) * (5054.872 / 4647.482) * (4647.482 / 2694.28)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= 0.9181 * 0.9663 * 12.99 % * 1.0877 * 1.7249
=21.63 %

Note: The net income data used here is four times the quarterly (Mar. 2026) net income data. The Revenue data used here is four times the quarterly (Mar. 2026) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


GPT Healthcare ROE % Related Terms


GPT Healthcare ROE % Historical Data

* Premium members only.

The historical data trend for GPT Healthcare's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

GPT Healthcare ROE % Chart

GPT Healthcare Annual Data
Trend Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
ROE %
Get a 7-Day Free Trial 28.53 24.11 24.89 21.41 16.32

GPT Healthcare Quarterly Data
Mar21 Mar22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 20.80 12.40 16.71 14.76 21.63

NSE:GPTHEALTH vs HCA, THC, DVA: ROE % Comparison

For the Medical Care Facilities subindustry, GPT Healthcare's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


GPT Healthcare ROE % vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, GPT Healthcare's ROE % distribution charts can be found below:

* The bar in red indicates where GPT Healthcare's ROE % falls into.


NSE:GPTHEALTH
43GF Score
GPT Healthcare Ltd NSE:GPTHEALTH
ROE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

GPT Healthcare ROE % Calculation

GPT Healthcare's annualized ROE % for the fiscal year that ended in Mar. 2026 is calculated as

ROE %=Net Income (A: Mar. 2026 )/( (Total Stockholders Equity (A: Mar. 2025 )+Total Stockholders Equity (A: Mar. 2026 ))/ count )
=422.205/( (2478.506+2694.28)/ 2 )
=422.205/2586.393
=16.32 %

GPT Healthcare's annualized ROE % for the quarter that ended in Mar. 2026 is calculated as

ROE %=Net Income (Q: Mar. 2026 )/( (Total Stockholders Equity (Q: Dec. 2025 )+Total Stockholders Equity (Q: Mar. 2026 ))/ count )
=582.64/( (0+2694.28)/ 1 )
=582.64/2694.28
=21.63 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Mar. 2026) net income data. ROE % is displayed in the 30-year financial page.

Frequently Asked Questions Learn more about ROE % →
What does a ROE % of 21.63% mean?
GPT Healthcare (NSE:GPTHEALTH) has a ROE % of 21.63% as of Mar. 2026. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on GPT Healthcare and its competitors. This is near median its historical median of 22.76. Over the past decade, GPT Healthcare's ROE % has ranged from 15.75 to 28.53. According to the industry distribution chart, GPT Healthcare ranks #134 out of 625 companies in the Healthcare Providers & Services industry, placing it in the top 21.4%.
Is GPT Healthcare's ROE % too high?
GPT Healthcare's current ROE % of 21.63% is near median its 10-year median of 22.76. Over the past 10 years, this metric has ranged from a low of 15.75 to a high of 28.53. The Healthcare Providers & Services industry median ROE % is 5.84. GPT Healthcare's value of 21.63% is 270.4% above this industry median. Based on the distribution chart, GPT Healthcare ranks #134 out of 625 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, GPT Healthcare has a GF Score™ of 43/100, reflecting its overall financial health beyond just this single metric.
How does GPT Healthcare's ROE % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, GPT Healthcare ranks #134 out of 625 companies for ROE %. This places GPT Healthcare in the top 21% of its industry — outperforming the majority of peers. The industry median ROE % is 5.84. GPT Healthcare's value of 21.63% is 270.4% above this benchmark. Historically, GPT Healthcare's own ROE % has ranged from 15.75 to 28.53 over the past decade. While the company's 10-year median is 22.76 vs. the industry median of 5.84, GPT Healthcare has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for a Healthcare Providers & Services company?
The median ROE % among Healthcare Providers & Services companies is 5.84, based on 625 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. GPT Healthcare's current ROE % of 21.63% is 270.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on GPT Healthcare and its competitors. For the Healthcare Providers & Services industry, the median ROE % is 5.84 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. GPT Healthcare's current ROE % is 21.63%, which is near median its own 10-year median of 22.76. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is GPT Healthcare stock overvalued right now?
GPT Healthcare (NSE:GPTHEALTH) has a current ROE % of 21.63%. The current ROE % is 21.63%, which is near median its 10-year median of 22.76 and 270.4% above the Healthcare Providers & Services industry median of 5.84. GPT Healthcare's overall GF Score™ is 43/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For GPT Healthcare (NSE:GPTHEALTH), the current ROE % is 21.63% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

GPT Healthcare Business Description

Other Exchanges 544131:India
Address Sector III, GPT Centre, JC-25, Salt Lake, Kolkata, WB, IND, 700106
GPT Healthcare Ltd is engaged in the healthcare sector. It operates a chain of mid-sized full-service hospitals under the ILS brand. It provides integrated healthcare services, with a focus on secondary and tertiary care and operates four multispecialty hospitals in Dum Dum, Salt Lake and Howrah in West Bengal and Agartala in Tripura with a total capacity of approximately 561 beds. It offers a comprehensive range of healthcare services across over 35 specialities and super specialities, including internal medicine and diabetology, nephrology (including renal transplants), laparoscopic and general surgery, gynaecology and obstetrics, critical care, gastroenterology, orthopaedics and joint replacements, interventional cardiology, neurology, neurosurgery, paediatrics, and neonatology.
43GF Score

Get the complete analysis for NSE:GPTHEALTH

ROE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹147.51
Price